Clinical trials: ADNP

ADNP Syndrome

Low-Dose Ketamine in Children With ADNP Syndrome

• Completed
• Age: 5 to 12 years
• Phase 1/2
• Results posted

This is a Phase 2A, single dose, open-label study to evaluate the safety, tolerability, and efficacy of a low-dose, 40-minute infusion into the veins (intravenous infusion or "IV") of ketamine in children with ADNP syndrome…

Trial name

NCT04388774

Testing

Ketamine

Where

United States

Volunteers

10 people

Sponsor

Alexander Kolevzon